Protocol 213503/047: To Compare the Immunogenicity and Safety of a Booster Dose of GSK Biologicals' DTaP-IPV Vaccine (Infanrix-IPV) Co-Administered with a Booster Dose of Merck & Co's M-M-RII, to that of Seperate Injections of GSK.....

Project: Research

Status	Finished
Effective start/end date	02/24/03 → 09/6/06

Project Details